News
The Board of Directors of Shiva Cement Limited, at its meeting held today have approved the financial results of the company ...
The Board of Directors of RPG Life Sciences Limited, at its meeting held today have approved the financial results of the ...
A daily rundown of the economic reports and corporate earnings that will be grabbing the market’s attention in the week ahead ...
In the fourth quarter, Shell nudged up its dividend to $0.3580 and Shell CEO Wael Sawan launched a $3.5bn share buyback for ...
Tempus AI (TEM) has seen a significant surge on Wednesday, with its stock climbing 14.62% in just one day. The significant boost in TEM stock ...
Discover how Cellectis SA (CLLS) is advancing its CAR T therapies and securing financial stability through strategic ...
Tempus AI reports 30.4% YoY revenue growth in FY2024, driven by genomics and data services. Discover key metrics and ...
While uncertainty remains high amid Trump's tariff blitz, Barclays analysts have highlighted six UK stock ideas for the ...
Eicher Motors, HDFC Bank, and SBI Cards hit new 52-week highs amid market volatility. Discover top performers now!
In Q4 2024, AstraZeneca PLC (NASDAQ:AZN) was included in 14 billionaire portfolios with a total of $2.20 billion in combined ...
AstraZeneca PLC (NASDAQ:AZN – Free Report) – Zacks Research cut their Q4 2026 EPS estimates for AstraZeneca in a research report issued on Wednesday, April 9th. Zacks Research analyst R.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results